Cargando…
Developing standards to support the clinical translation of stem cells
Stem cells, which could be developed as starting or raw materials for cell therapy, hold tremendous promise for regenerative medicine. However, despite multiple fundamental and clinical studies, clinical translation of stem cells remains in the early stages. In contrast to traditional chemical drugs...
Autores principales: | Cao, Jiani, Hao, Jie, Wang, Lei, Tan, Yuanqing, Tian, Yuchang, Li, Shiyu, Ma, Aijin, Fu, Boqiang, Dai, Jianwu, Zhai, Peijun, Xiang, Peng, Zhang, Yong, Cheng, Tao, Peng, Yaojin, Zhou, Qi, Zhao, Tongbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560191/ https://www.ncbi.nlm.nih.gov/pubmed/34724717 http://dx.doi.org/10.1002/sct3.13035 |
Ejemplares similares
-
Human retinal pigment epithelial cells
por: Wang, Lei, et al.
Publicado: (2021) -
Developing standards to support cell technology applications
por: Cao, Jiani, et al.
Publicado: (2022) -
Human mesenchymal stem cells
por: Chen, Xiaoyong, et al.
Publicado: (2021) -
Requirements for human‐induced pluripotent stem cells
por: Zhang, Ying, et al.
Publicado: (2022) -
Requirements for human cardiomyocytes
por: Yu, Miao, et al.
Publicado: (2021)